Slogan: European Patients' Academy on Therapeutic Innovation
Description: EUPATI provides education and training for patients and patient representatives on the process of medicines research and development (R&D). The trained patient experts are key to realizing meaningful patient engagement in medicines R&D, regulatory deliberations, and other activities. EUPATI was established by the Innovative Medicines Initiative (IMI) in 2012 and was hosted by the European Patients’ Forum (EPF) as a Public-Private Partnership Programme 2017-2020. EUPATI is today established as an independent non-profit Foundation in the Netherlands and has 24 National Platforms in Europe and in Japan. "We focus on education and training to increase the capacity and capability of patients to be valuable contributors to medicines research and development by working with patients and the stakeholders they collaborate with."
Industries: Education
Headquarter: Not available
Last Investment: Not available
Last Investment Investors: Not available
EUPATI, founded in 2012, aims to empower patients and patient representatives by providing them with education and training in the medicines research and development process. The organization is focused on increasing the capacity and capability of patients to contribute meaningfully to the field. It was initially established by the Innovative Medicines Initiative (IMI), and after being hosted by the European Patients’ Forum (EPF), it now operates as an independent non-profit Foundation in the Netherlands. With 24 National Platforms in Europe and Japan, EUPATI emphasizes the importance of patient engagement in medicines R&D and regulatory activities. Although specific details about recent investments and investors are not available, the organization's commitment to patient education and advocacy presents an opportunity for potential future collaborations and growth.
